Gene · 5927
Papers1,684
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,684
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas. | Sci Rep | 2023 | 37880235 | PubTator, text mining | PubMed |
| Oxygen-regulated post-translation modifications as master signalling pathway in cells. | EMBO Rep | 2023 | 37877678 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals a systemic immune dysregulation in COVID-19-associated pediatric encephalopathy. | Signal Transduct Target Ther | 2023 | 37848421 | PubTator, text mining | PubMed |
| Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development. | Nat Commun | 2023 | 37845228 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Domain architecture and protein-protein interactions regulate KDM5A recruitment to the chromatin. | Epigenetics | 2023 | 37838974 | PubTator, text mining | PubMed |
| Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2023 | 37835428 | PubTator, text mining | PubMed |
| Clinical Potential of Cellular Material Sources in the Generation of iPSC-Based Products for the Regeneration of Articular Cartilage. | Int J Mol Sci | 2023 | 37833856 | PubTator, text mining | PubMed |
| Recent developments in catalysis and inhibition of the Jumonji histone demethylases. | Curr Opin Struct Biol | 2023 | 37832177 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma. | Med Oncol | 2023 | 37831226 | PubTator, text mining | PubMed |
| The odontoblastic differentiation of dental mesenchymal stem cells: molecular regulation mechanism and related genetic syndromes. | Front Cell Dev Biol | 2023 | 37818127 | PubTator, text mining | PubMed |
| Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions. | Front Oncol | 2023 | 37817767 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitor-related molecular markers predict prognosis in extrahepatic cholangiocarcinoma. | Cancer Med | 2023 | 37814942 | PubTator, text mining | PubMed |
| KDM5-mediated activation of genes required for mitochondrial biology is necessary for viability in Drosophila. | Development | 2023 | 37800333 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens and their applications in infectious disease. | Front Genome Ed | 2023 | 37794981 | PubTator, text mining | PubMed |
| HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. | Curr Issues Mol Biol | 2023 | 37754227 | PubTator, text mining | PubMed |
| KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic. | Adv Exp Med Biol | 2023 | 37751138 | PubTator, text mining | PubMed |
| Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer. | Chin Med | 2023 | 37749560 | PubTator, text mining | PubMed |
| A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients. | Aging (Albany NY) | 2023 | 37737707 | PubTator, text mining | PubMed |
| Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment. | Noncoding RNA | 2023 | 37736898 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5927/papers?page=8